Robbins Geller Rudman & Dowd LLP filed a class-action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS). The legal action represents investors who purchased securities between August 4, 2025, and July 29, 2026.
The lawsuit alleges Hims & Hers shared sensitive consumer health information with third-party advertising platforms. It further claims the company charged for prescriptions immediately, despite promising prior medical consultations.
The Federal Trade Commission filed a complaint regarding these allegations in July 2026. Investors have until November 2, 2026, to seek lead plaintiff status.